Low-scale Supersymmetry from Inflation

We investigate an inflation model with the inflaton being identified with a Higgs boson responsible for the breaking of U(1)B-L symmetry. We show that supersymmetry must remain a good symmetry at scales one order of magnitude below the inflation scale, in order for the inflation model to solve the horizon and flatness problems, as well as to account for the observed density perturbation. The upper bound on the soft supersymmetry breaking mass lies between 1TeV and 10^3TeV. Interestingly, our finding opens up a possibility that universes with the low-scale supersymmetry are realized by the inflationary selection. Our inflation model has rich implications; non-thermal leptogenesis naturally works, and the gravitino and moduli problems as well as the moduli destabilization problem can be solved or ameliorated; the standard-model higgs boson receives a sizable radiative correction if the supersymmertry breaking takes a value on the high side ~10^3TeV.Comment: 23pages, 3 figures. v2: references adde

Pion photoproduction in a dynamical coupled-channel model

Pion photoproduction reactions are investigated in a dynamical coupled-channel approach based on the Juelich pi-N model, which presently includes the hadronic pi-N and eta-N stable channels as well as the pi-Delta, sigma-N and rho-N effective channels. This model has been quite successful in the description of pi-N to pi-N scattering for center-of-mass energies up to 1.9 GeV. The full pion photoproduction amplitude is constructed to satisfy the generalized Ward-Takahashi identity and hence, it is fully gauge invariant. The calculated differential cross sections and photon spin asymmetries up to 1.65 GeV center-of-mass energy for the reactions gamma p to pi+ n, gamma p to pi0 p and gamma n to pi- p are in good agreement with the experimental data.Comment: Invited talk given at 12th International Conference on Meson-Nucleon Physics and the Structure of the Nucleon (MENU2010), Williamsburg, USA, May 31-June 4 201

The phase and pole structure of the N*(1535) in piN-->piN and gammaN-->piN

The nature of some baryonic resonances is still an unresolved issue. The case of the N*(1535) is particularly interesting in this respect due to the nearby etaN threshold and interference with the N*(1650). The N*(1535) has been described as a threshold effect, as a genuine 3-quark resonance, or as dynamically generated from the interaction of the octet of baryons with the octet of mesons. In the scheme of dynamical generation, predictions for the interaction of the N*(1535) with the photon can be made. In this study, we simultaneously analyze the role of the N*(1535) in the piN-->piN and gammaN-->piN reactions and compare to the respective amplitudes from partial wave analyses. This test is very sensitive to the meson-baryon components of the N*(1535).Comment: 22 pages, 16 figures; updated to revised version accepted by EPJ

Smectic layer rotation by dc field in ferroelectric liquid crystal

This article may be downloaded for personal use only. Any other use requires prior permission of the author and AIP Publishing. This article appeared in K. Nakayama, M. Ozaki, and K. Yoshino, Appl. Phys. Lett. 70, 2117 (1997) and may be found at https://doi.org/10.1063/1.118966

KRAS or BRAF mutation status is a useful predictor of sensitivity to MEK inhibition in ovarian cancer

This study examined the status of KRAS and BRAF mutations, in relation to extracellular signal-regulated protein kinase (ERK) activation in 58 ovarian carcinomas to clarify the clinicopathological and prognostic significance of KRAS/BRAF mutations. Somatic mutations of either KRAS or BRAF were identified in 12 (20.6%) out of 58 ovarian carcinomas. The frequency of KRAS/BRAF mutations in conventional serous high-grade carcinomas (4.0% : 1/25) was significantly lower than that in the other histological type (32.3% : 10/31). Phosphorylated ERK1/2 (p-ERK1/2) expression was identified in 18 (38.2%) out of 45 ovarian carcinomas. KRAS/BRAF mutation was significantly correlated with International Federation of Gynecology and Obstetrics (FIGO) stage I, II (P<0.001), and p-ERK1/2 (P<0.001). No significant correlations between KRAS/BRAF mutations or p-ERK1/2 expression and overall survival were found in patients with ovarian carcinoma treated with platinum and taxane chemotherapy (P=0.2460, P=0.9339, respectively). Next, to clarify the roles of ERK1/2 activation in ovarian cancers harbouring KRAS or BRAF mutations, we inactivated ERK1/2 in ovarian cancer cells using CI-1040. Cl-1040 is a compound that selectively inhibits MAP kinase kinase (MEK), an upstream regulator of ERK1/2, and thus prevents ERK1/2 activation. Profound growth inhibition and apoptosis were observed in CI-1040-treated cancer cells with mutations in either KRAS or BRAF in comparison with the ovarian cancer cells containing wild-type sequences. This was evident in both in vitro and in vivo studies. The findings in this study indicate that an activated ERK1/2 pathway is critical to tumour growth and survival of ovarian cancers with KRAS or BRAF mutations. Furthermore, they suggest that the CI-1040-induced phenotypes depend on the mutational status of KRAS and BRAF in ovarian cancers. Therefore, ovarian cancer patients with KRAS or BRAF mutations may benefit from CI-1040 treatment

Superfield Formulation for Non-Relativistic Chern-Simons-Matter Theory

We construct a superfield formulation for non-relativistic Chern-Simons-Matter theories with manifest dynamical supersymmetry. By eliminating all the auxiliary fields, we show that the simple action reduces to the one obtained by taking non-relativistic limit from the relativistic Chern-Simons-Matter theory proposed in the literature. As a further application, we give a manifestly supersymmetric derivation of the non-relativistic ABJM theory.Comment: 18 page